Literature DB >> 28104980

Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody.

Yuichi Matsuo1, Yasutoshi Kido1, Junko Akada1, Seiji Shiota1, Tran Thanh Binh1, Tran Thi Huyen Trang1, Ho D Q Dung1, Pham Huu Tung1, Tran Dinh Tri1, Ngo P Minh Thuan1, Le Quang Tam1, Bui Chi Nam1, Vu Van Khien1, Yoshio Yamaoka1.   

Abstract

AIM: To develop a novel Helicobacter pylori (H. pylori) CagA antibody enzyme-linked immunosorbent assay (ELISA) suitable for detecting serum anti-CagA antibodies with high sensitivity.
METHODS: Recombinant East Asian-type CagA protein was purified and immobilized for ELISA. Serum samples from 217 Vietnamese individuals (110 H. pylori-infected and 107 uninfected individuals) were applied. Conventional ELISA from Western-type CagA and our East Asian-type CagA ELISA were evaluated by comparing 38 subjects with the Western-type genotype and 72 subjects with the East Asian-type cagA genotype. Histological scores of the gastric mucosa were determined using the updated Sydney System to examine the relationship with anti-CagA antibody titers.
RESULTS: Recombinant 70-100 kDa fragments were immobilized on the ELISA plate. In ROC analysis, the area under the curve of our East Asian-type CagA ELISA was comparable to that of conventional CagA ELISA. The sensitivity of the two ELISAs differed depending on the cagA genotype. The sensitivity of East Asian-type CagA ELISA was higher for subjects infected with East Asian-type cagA H. pylori (P < 0.001), and the sensitivity of the conventional CagA ELISA tended to be higher for subjects infected with Western cagA H. pylori (P = 0.056). The titer of anti-CagA antibody tended to correlate with monocyte infiltration scores (r = 0.25, P = 0.058) and was inversely correlated with H. pylori density (r = -0.26, P = 0.043).
CONCLUSION: The novel ELISA is useful to detect anti-CagA antibodies in East Asian countries, and the titer may be a marker for predicting chronic gastritis.

Entities:  

Keywords:  Anti-CagA antibody; Enzyme-linked immunosorbent assay; Gastritis; Helicobacter pylori; Inflammation; cagA genotype

Mesh:

Substances:

Year:  2017        PMID: 28104980      PMCID: PMC5221286          DOI: 10.3748/wjg.v23.i1.48

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.

Authors:  S Maeda; H Yoshida; K Ogura; Y Yamaji; T Ikenoue; T Mitsushima; H Tagawa; R Kawaguchi; K Mori; K i Mafune; T Kawabe; Y Shiratori; M Omata
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

3.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

4.  Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan.

Authors:  Osamu Matsunari; Seiji Shiota; Rumiko Suzuki; Masahide Watada; Nagisa Kinjo; Kazunari Murakami; Toshio Fujioka; Fukunori Kinjo; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

5.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.

Authors:  E J Kuipers; G I Pérez-Pérez; S G Meuwissen; M J Blaser
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

6.  Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects.

Authors:  J Kreuning; J Lindeman; I Biemond; C B Lamers
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

7.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer.

Authors:  Jia Qing Huang; Ge Fan Zheng; Katica Sumanac; E Jan Irvine; Richard H Hunt
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

Review 8.  Oncogenic mechanisms of the Helicobacter pylori CagA protein.

Authors:  Masanori Hatakeyama
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

9.  CagA seropositivity associated with development of gastric cancer in a Japanese population.

Authors:  T Shimoyama; S Fukuda; M Tanaka; T Mikami; A Munakata; J E Crabtree
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

10.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

View more
  6 in total

1.  Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.

Authors:  Shamshul Ansari; Junko Akada; Yuichi Matsuo; Seiji Shiota; Yoko Kudo; Tadayoshi Okimoto; Kazunari Murakami; Yoshio Yamaoka
Journal:  J Gastroenterol       Date:  2019-05-02       Impact factor: 7.527

2.  Multiplex Accelerated PCR System for One-Step Helicobacter pylori cagA + Genotypes Detection: A Guide for Clinical Testing.

Authors:  Yanling Wang; Yang Li; Zhixian Luan; Yan Zhao; Peng Zhang; Cuiping Ma; Chao Shi
Journal:  Curr Microbiol       Date:  2022-06-29       Impact factor: 2.188

3.  Characterization of a novel Helicobacter pylori East Asian-type CagA ELISA for detecting patients infected with various cagA genotypes.

Authors:  Dalla Doohan; Muhammad Miftahussurur; Yuichi Matsuo; Yasutoshi Kido; Junko Akada; Takeshi Matsuhisa; Than Than Yee; Kyaw Htet; Hafeza Aftab; Ratha-Korn Vilaichone; Varocha Mahachai; Thawee Ratanachu-Ek; Lotay Tshering; Langgeng Agung Waskito; Kartika Afrida Fauzia; Tomohisa Uchida; Ari Fahrial Syam; Yudith Annisa Ayu Rezkitha; Yoshio Yamaoka
Journal:  Med Microbiol Immunol       Date:  2019-09-23       Impact factor: 3.402

4.  Designing a novel ELISA method based on CagA, NapA recombinant antigens to increase sensitivity and specificity of Helicobacter pylori whole cell antigen detection.

Authors:  Farideh Kamarehei; Alireza Khabiri; Massoud Saidijam; Meysam Soleimani; Mohammad Yousef Alikhani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

5.  Assessment of the diagnostic accuracy and relevance of a novel ELISA system developed for seroepidemiologic surveys of Helicobacter pylori infection in African settings.

Authors:  Evariste Tshibangu-Kabamba; Bui Hoang Phuc; Vo Phuoc Tuan; Kartika Afrida Fauzia; Augustin Kabongo-Tshibaka; Nadine Kalenda Kayiba; Angel Rosas-Aguirre; Brecht Devleesschauwer; Alain Cimuanga-Mukanya; Patrick de Jésus Ngoma Kisoko; Takashi Matsumoto; Junko Akada; Ghislain Tumba Disashi; Dieudonné Mumba Ngoyi; Yasutoshi Kido; Niko Speybroeck; Yoshio Yamaoka
Journal:  PLoS Negl Trop Dis       Date:  2021-09-09

6.  Endoscopy-based Kyoto classification score of gastritis related to pathological topography of neutrophil activity.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Shuntaro Yoshida; Yoshiki Sakaguchi; Yousuke Nakai; Hidenobu Watanabe; Hidekazu Suzuki; Chizu Tanikawa; Koichi Matsuda; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.